FDA Inspections of Clinical Investigators: Understanding the Process and What to Expect
A Food and Drug Administration (FDA) inspection of a clinical investigator can occur at any time. The FDA conducts inspections of clinical investigators to verify clinical trial data submitted to FDA; to ensure that the rights, safety, and welfare of human subjects enrolled in FDA-regulated clinical trials are protected; and to assess regulatory compliance. By understanding the clinical investigator inspection process and learning how to address inspectional findings, your involvement in an FDA inspection could be transformed into a less stressful and more positive experience.
In this webinar, Advarra’s Constance Cullity, Senior Director, Regulatory Compliance, and Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, will provide an overview of the clinical investigator inspection process and what to expect.
Learning Objectives:
- Identify the types of clinical investigator inspections: routine and for-cause
- Outline the inspection process and what information will be evaluated and considered during an inspection
- Summarize best practices for addressing inspectional findings during and after an inspection
Presented By

Constance Cullity
MD, MPH
Senior Director, Regulatory Compliance
Advarra
Moderated By

Michele Russell-Einhorn
JD
Chief Compliance Officer and Institutional Official
Advarra
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
DATE: April 8, 2021
Time: 1 pm ET | 10 am PT
Duration: 1 hour